CanadaMax Slim Alpha-GPC + Citicoline capsules (NPN 80129088), Lot G9P12C24; strength: Cytidine 5'-(trihydrogen diphosphate) P'-[2-(trimethylammonio)ethyl] ester inner salt 400 mg and L‑alpha‑Glycerophosphorylcholine 400 mg. The affected lot was recalled because it contains an undeclared ingredient (caffeine). Verify if your product is Lot G9P12C24, consult your healthcare provider before discontinuing use or for health concerns, contact the recalling firm with questions, and report any side effects or safety complaints to Health Canada.
What's being recalled
Depth of Recall: Retailers
Companies: Maximum Slim, 2114 N. Flamingo Rd #202, Pembroke Pines, FL, 33028, USA.
How to identify it
Product Name: Max Slim Alpha-GPC + Citicoline; Market Authorization: NPN 80129088; Dosage Form: Capsule; Strength: Cytidine 5'-(trihydrogen diphosphate) P'-[2-(trimethylammonio)ethyl] ester inner salt 400mg L-alpha-Glycerophosphorylcholine 400mg; Lot number: G9P12C24
The hazard
The affected lot contains an undeclared ingredient (caffeine).
What to do
Verify if your product is affected.
Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
Contact the recalling firm if you have any questions about the recall.
Report any health product related side effects to Health Canada.
Report any other health product safety complaints to Health Canada.
Where it was sold
National
The official notice
This page is a summary of the notice published by Health Canada, collected from Health Canada, CFIA and Transport Canada. Check the original before you act on it.
Read the official notice (opens in a new tab)